Hospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study

    BMC Cancer, Vol. 22, Núm. 1